HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Apparent worsening of psoriasis lesions revealing methotrexate overdosage].

AbstractBACKGROUND:
Methotrexate (MTX) is an antimetabolite drug used in the treatment of cancers and autoimmune diseases and frequently in dermatology for cutaneous and/or arthritic psoriasis. Toxicities due to MTX overdosage are mainly cutaneous, hepatic and hematologic. Herein, we report a case of MTX overdosage presenting as an erosive and an inflammatory flare of preexisting psoriatic plaques and with new palmar lesions.
PATIENTS AND METHODS:
A 51-year-old male with a 6-year history of plaque psoriasis resistant to topical corticosteroids was started for the first time on MTX 20mg weekly. One week later, he presented with fever, general weakness and mucocutaneous ulcerations. Physical examination revealed inflammatory, erythematous and partially erosive annular plaques strictly confined to preexisting psoriatic lesions, along with keratotic psoriatic palmar plaques. Further questioning indicated that the patient was taking MTX 20mg daily. Investigations revealed neutropenia (1040/mm3) and skin histology showed prominent dystrophic keratinocytes and confirmed the diagnosis of methotrexate toxicity. Clinical and biological improvements were observed after cessation of MTX and treatment with folinic acid, IV hydration and urine alkalization.
DISCUSSION:
Skin lesions due to acute MTX toxicity are rare, but they herald later-onset pancytopenia. Identification of these cutaneous lesions might enable earlier treatment initiation. The predilection of MTX toxicity for preexisting lesions or the de novo appearance of palmoplantar pustules should not lead to the erroneous diagnosis of psoriasis flare.
AuthorsR Haber, B Baroudjian, M Battistella, M Bagot, A Petit
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 145 Issue 2 Pg. 104-108 (Feb 2018) ISSN: 0151-9638 [Print] France
Vernacular TitleAggravation apparente d’un psoriasis révélant un surdosage en méthotrexate.
PMID28917574 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2017 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Dermatologic Agents
  • Methotrexate
Topics
  • Dermatologic Agents (adverse effects)
  • Drug Eruptions (etiology)
  • Drug Overdose
  • Humans
  • Male
  • Methotrexate (administration & dosage, adverse effects)
  • Middle Aged
  • Psoriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: